Erdafitinib in Asian patients with advanced solid tumors: an open-label, single-arm, phase IIa trial. Park JO, Feng YH, Su WC, Oh DY, et al. BMC Cancer 2024;24:1006.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Park JO, Feng YH, Su WC, Oh DY, et al. Erdafitinib in Asian patients with advanced solid tumors: an open-label, single-arm, phase IIa trial. BMC Cancer 2024;24:1006.
PMID: 39138436